Anthera Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
25,946.00
2,639.00
46,951.00
20,843.00
2,196.00
Total Accounts Receivable
-
-
326.00
-
-
Other Current Assets
358.00
383.00
585.00
1,865.00
995.00
Total Current Assets
26,304.00
3,022.00
47,862.00
22,708.00
3,191.00
Net Property, Plant & Equipment
812.00
468.00
263.00
763.00
482.00
Total Investments and Advances
10,000.00
-
-
-
-
Other Assets
301.00
-
-
-
-
Total Assets
37,417.00
3,490.00
48,125.00
23,471.00
3,673.00
ST Debt & Current Portion LT Debt
2,777.00
-
-
-
-
Accounts Payable
3,519.00
-
5,259.00
4,782.00
1,832.00
Other Current Liabilities
1,265.00
5,751.00
3,209.00
5,842.00
2,879.00
Total Current Liabilities
7,561.00
5,751.00
8,468.00
10,624.00
4,711.00
Long-Term Debt
15,098.00
-
-
-
-
Other Liabilities
-
-
-
-
4,457.00
Total Liabilities
22,659.00
5,751.00
8,468.00
10,624.00
9,168.00
Common Equity (Total)
14,758.00
2,261.00
39,657.00
3,856.00
5,828.00
Total Shareholders' Equity
14,758.00
2,261.00
39,657.00
12,847.00
5,495.00
Total Equity
14,758.00
2,261.00
39,657.00
12,847.00
5,495.00
Liabilities & Shareholders' Equity
37,417.00
3,490.00
48,125.00
23,471.00
3,673.00
Preferred Stock (Carrying Value)
-
-
-
8,991.00
333.00
About Anthera Pharmaceuticals
View Profile
